OLIPASS (Korea) Today
| 244460 Stock | KRW 2,445 65.00 2.73% |
Performance0 of 100
| Odds Of DistressLess than 21
|
OLIPASS is trading at 2445.00 as of the 31st of January 2025, a 2.73% increase since the beginning of the trading day. The stock's open price was 2380.0. OLIPASS has about a 21 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 11th of February 2023 and ending today, the 31st of January 2025. Click here to learn more.
OLIPASS Corporation focuses on developing therapeutic products in South Korea. OLIPASS Corporation was founded in 2006 and is headquartered in Yongin, south Korea. Olipass is traded on Korean Securities Dealers Automated Quotations in South Korea. More on OLIPASS
Moving against OLIPASS Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
OLIPASS Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. OLIPASS's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding OLIPASS or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
OLIPASS (244460) is traded on KOSDAQ in Korea and employs 93 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 180.69 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate OLIPASS's market, we take the total number of its shares issued and multiply it by OLIPASS's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. OLIPASS operates under Healthcare sector and is part of Biotechnology industry.
OLIPASS has accumulated about 8.66 B in cash with (19.62 B) of positive cash flow from operations.
Check OLIPASS Probability Of Bankruptcy
Ownership AllocationThe market capitalization of OLIPASS is W180.69 Billion. OLIPASS has noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the company is larger than the current market value, you may still be able to generate positive returns on investment in this company.
Check OLIPASS Ownership Details
OLIPASS Risk Profiles
Although OLIPASS's alpha and beta are two of the key measurements used to evaluate OLIPASS's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.94 | |||
| Standard Deviation | 5.78 | |||
| Variance | 33.37 | |||
| Risk Adjusted Performance | (0.15) |
OLIPASS Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in OLIPASS without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Exposure Probability Now
Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets |
| All Next | Launch Module |
Other Information on Investing in OLIPASS Stock
OLIPASS financial ratios help investors to determine whether OLIPASS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in OLIPASS with respect to the benefits of owning OLIPASS security.